Page 213 - Pagetit
P. 213

NEUROSCIENCE OF PSYCHOACTIVE SUBSTANCE USE AND DEPENDENCE



                   References

                   Adler LE et al. (1998) Schizophrenia, sensory gating and nicotinic receptors.
                   Schizophrenia Bulletin, 24:189–202.
                                             a
                   Allen AR et al. (1997) The 5-HT1  receptor antagonist p-MPPI blocks responses
                                                             a
                   mediated by postsynaptic and presynaptic 5-HT1  receptors. Pharmacology,
                   Biochemistry and Behavior, 57:301–307.
                   Allen RM, Young SJ (1978) Phencyclidine-induced psychosis. American Journal
                   of Psychiatry, 135:1081–1084.
                   American Psychiatric Association (1994) Diagnostic and statistical manual of
                   mental disorders- Fourth EditonWashington, DC, American Psychiatric Press.
                   Andrews N, File SE (1993) Increased 5-HT release mediates the anxiogenic
                   response during benzodiazepine withdrawal: a review of supporting
                   neurochemical and behavioural evidence. Psychopharmacology, 112:21–25.
                   Angrist B, Gershon S (1970) The phenomenology of experimentally-induced
                   amphetamine psychosis: preliminary observations. Biological Psychiatry, 2:95–
                   107.
                   Angrist B, Rotrosen J, Gershon S (1980) Differential effects of amphetamine and
                   neuroleptics on negative and positive symptoms in schizophrenia.
                   Psychopharmacology, 72:17–19.
                   Angrist B et al. (1982) Partial improvement in negative schizophrenic symptoms
                   after amphetamine. Psychopharmacology, 78:128–130.
                   Ascher JA et al. (1995) Bupropion: a review of its mechanisms of antidepressant
                   activity. Journal of Clinical Psychiatry, 56:395–401.
                   Aubin HJ, Tilikete S, Barrucand D (1996) Depression and smoking. Encephale,
                   22:17–22.
                   Balla A et al. (2001) Phencyclidine-induced dysregulation of dopamine response
                   to amphetamine in prefrontal cortex and striatum. Neurochemistry Research,
                   26:1001–1006.
                   Bel N, Artigas F (1993) Chronic treatment with fluvoxamine increases extracellular
                   serotonin in the frontal cortex but not in raphe nuclei. Synapse, 15:243–245.
                   Bell DS (1965) Comparison of amphetamine psychosis and schizophrenia. British
                   Journal of Psychiatry, 111:701–707.
                   Benkelfat C et al. (1994) Mood-lowering effect of tryptophan depletion: enhanced
                   susceptibility in young men at genetic risk for major affective disorders. Archives
                   of General Psychiatry, 51:687–697.
                   Beyer CE, Steketee JD (2000) Intra-medial prefrontal cortex injection of
                   quinpirole, but not SKF 38393, blocks the acute motor-stimulant response to
                   cocaine in the rat. Psychopharmacology, 151:211–218.
                   Binder RL et al. (1987) Smoking and tardive dyskinesia. Biological Psychiatry,
                   22:1280–1282.
                   Blaha CD et al. (1997) Stimulation of the ventral subiculum of the hippocampus
                   evokes glutamate receptor-mediated changes in dopamine efflux in the rat
                   nucleus accumbens. European Journal of Neuroscience, 9:902–911.


                                                  192




          Chapter_6                192                             19.1.2004, 11:48
   208   209   210   211   212   213   214   215   216   217   218